| Issue |
Title |
File |
| Vol 16, No 1 (2014) |
Clinical cases of treatment of hepatocellular carcinoma |
|
|
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
|
| Vol 20, No 1 (2018) |
Clinical cases of treatment of patients with advanced hepatocellular carcinoma |
(Rus)
|
|
Petkau V.V., Gladkov O.A., Filatov P.N., Raigorodskii M.V., Tarkhanov A.A., Klimushkin A.V., Nikitina L.Y.
|
| Vol 15, No 4 (2013) |
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney |
|
|
Klimenko A.A., Ivanov S.A.
|
| Vol 16, No 3 (2014) |
Clinical experience with abiraterone acetate application in patients with castration-resistant prostate cancer |
|
|
Gridneva Y.V., Matveev V.B., Kupchan D.Z., Kalinin S.A., Peters M.V.
|
| Vol 25, No 1 (2023) |
Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study |
(Rus)
|
|
Golubenko E.O., Savelyeva M.I., Poddubnaya I.V., Korennaya V.V.
|
| Vol 18, No 5 (2016) |
Clinical features and therapy of double-hit and double-expressor lymphomas |
|
|
Baryakh E.A., Misyurina A.E., Kovrigina A.M., Obukhova T.N., Kravchenko S.K., Magomedova A.U., Zingerman B.V., Misyurina E.N., Poteshkina N.G., Lysenko M.A., Vorobev A.I.
|
| Vol 20, No 3 (2018) |
Clinical prognostic factors of bilateral synchronous renal cancer |
(Rus)
|
|
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
|
| Vol 26, No 3 (2024) |
Clinical significance of PET/CT in the diagnosis of primary adrenal malignancies |
(Rus)
|
|
Ognerubov N.A., Antipova T.S., Mirsalimova O.O., Poddubnaya I.V.
|
| Vol 20, No 1 (2018) |
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia |
(Rus)
|
|
Mirolyubova Y.V., Stadnik E.A.
|
| Vol 25, No 2 (2023) |
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study |
(Rus)
|
|
Zhurman V.N.
|
| Vol 18, No 3 (2016) |
Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene |
(Rus)
|
|
Ryazhenov V.V., Gorokhova S.G.
|
| Vol 19, No 2 (2017) |
Clinico-morphological predictors and treatment outcomes in cervical stump cancer |
(Rus)
|
|
Usmanova L.S., Kuznetsov V.V., Mustafina E.A., Barinov V.V., Bokin I.I., Knyazev R.I., Akhmedova M.D.
|
| Vol 25, No 3 (2023) |
Colon cancer-induced sarcopenia: clinical and radiological correlations |
(Rus)
|
|
Lyadov V.K., Fedorinov D.S., Lyadova M.A., Khristenko E.A., Boldyreva T.S., Galkin V.N.
|
| Vol 25, No 1 (2023) |
Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report |
(Rus)
|
|
Orlova K.V., Petenko N.N., Garanina N.V., Demidov L.V.
|
| Vol 24, No 4 (2022) |
Combination of microspheres and gadoteridol for the determination of non-target ovarian embolization during uterine artery embolization. A case series |
(Rus)
|
|
Sharafutdinov B.M., Ryzhkin S.A., Galim'yanov D.A., Gaziev E.A.
|
| Vol 24, No 2 (2022) |
Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review |
(Rus)
|
|
Zukov R.A., Chernyaev D.V., Zulkaidarova A.R.
|
| Vol 15, No 1 (2013) |
Combined and complex treatment options for patients with operable rectal cancer |
|
|
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
|
| Vol 25, No 4 (2023) |
Comorbid pathology in SARS-CoV-2 infected in cancer practice as a predictor of severe outcomes in COVID-19. COVID-19 prognostic online risk assessment tool in oncology: A retrospective study |
(Rus)
|
|
Sekacheva M.I., Rusanov A.S., Kokhanovskaia I.I.
|
| Vol 26, No 3 (2024) |
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study |
(Rus)
|
|
Pokataev I.A., Stativko O.A., Volkova M.I., Fedorova A.N., Zueva E.V., Ibragimova M.R., Tsareva E.V., Antonova T.G., Sinitsyna O.R., Cherniaev V.A., Gridneva Y.V., Oskarev A.V., Galkin V.N.
|
| Vol 22, No 3 (2020) |
Comparative analysis of the effectiveness of «Chaos and Clues», «Triage Amalgamated Dermoscopic Algorithm» dermatoscopic algorithms and BLINСK techniques in the diagnosis of melanoma and other skin cancers depending on previous dermatoscopy experience |
(Rus)
|
|
Silina L.V., Khvostovoi V.V., Ovsianikov V.V., Zubtsov M.S.
|
| Vol 23, No 4 (2021) |
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer |
(Rus)
|
|
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
|
| Vol 17, No 4 (2015) |
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas |
|
|
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
|
| Vol 23, No 3 (2021) |
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis |
(Rus)
|
|
Goryaynov S.V.
|
| Vol 26, No 3 (2024) |
Comparison of efficacy and safety of regorafenib and anti-EGFR targeted therapy in metastatic colorectal cancer: A retrospective study |
(Rus)
|
|
Kuzmina E.S., Fedyanin M.Y., Lyadova M.A., Fedorinov D.S., Polyanskiy M.A., Parts S.A., Pokataev I.A., Galkin V.N.
|
| Vol 23, No 1 (2021) |
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data |
(Rus)
|
|
Bogdanov A.A., Moiseenko F.V., Egorenkov V.V., Bogdanov A.A., Volkov N.M., Fedyanin M.Y.
|
| Vol 26, No 3 (2024) |
Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study |
(Rus)
|
|
Semenov N.N., Izrailov R.E., Semenov N.E., Zhukova L.G., Feoktistova P.S., Matveychuk D.A., Khatkov I.E.
|
| Vol 21, No 3 (2019) |
Complex radiologic imaging of early breast cancer (literature review) |
(Rus)
|
|
Aliyeva G.S., Korzhenkova G.P., Kolyadina I.V.
|
| Vol 24, No 1 (2022) |
Comprehensive rehabilitation of cancer patients: A review |
(Rus)
|
|
Gameeva E.V., Stepanova A.M., Tkachenko G.A., Gridnev O.V., Sviridov S.V., Shestopalov A.E.
|
| Vol 18, No 1 (2016) |
Concerning selective neck dissections in oral squamous cell carcinoma |
(Rus)
|
|
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
|
| Vol 25, No 4 (2023) |
Correction of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report |
(Rus)
|
|
Obukhova O.A., Dibirova P.A., Kurmukov I.A., Allakhverdiyan G.S., Shagina N.Y., Mustafina E.А., Knyazev R.I., Pajanidi J.G.
|
| Vol 20, No 1 (2018) |
Cost-effectiveness analysis of ixabepilone use in monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin |
(Rus)
|
|
Kolbin A.S., Mosikyan A.A., Balykina Y.E., Proskurin M.A.
|
| Vol 18, No 2 (2016) |
Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast |
(Rus)
|
|
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
|
| Vol 26, No 3 (2024) |
Cost-effectiveness of using granulocyte colony-stimulating factor in the treatment of uterine body leiomyosarcomas. A retrospective analysis |
(Rus)
|
|
Saevets V.V., Kuzmin N.K., Shamanova A.Y., Mukhin A.A., Taratonov A.V.
|
| Vol 24, No 2 (2022) |
Creating a story on the pages of a book about diffuse B-large cell lymphoma |
(Rus)
|
|
Editorial B.
|
| Vol 27, No 1 (2025) |
Cryoablation of prostate cancer: existing limitations and prospects for further development. A review |
(Rus)
|
|
Vasilyev A.O., Pushkarev A.V., Govorov A.V., Saakyan N.Y., Tsiganov D.I.
|
| Vol 25, No 3 (2023) |
CT sarcometry in the prediction of postoperative complications in patients with gastric cancer: Retrospective cohort study |
(Rus)
|
|
Agababyan T.A., Kukarskaya V.A., Silanteva N.K., Potapov A.L., Skoropad V.Y., Sheberova E.V., Dorozhkin A.D., Ivanov S.А., Kaprin A.D.
|
| Vol 14, No 2 (2012) |
Cubpopulyatsionnyy sostav i tsitokinsekretornaya funktsiya kletok produkta separatsii u bol'nykh limfomami |
|
|
Baranova D.S., Sakhno L.V., Kryuchkova I.V., Pronkina N.V., Batorov E.V., Tikhonova M.A., Gilevich A.V., Sergeevicheva V.V., Sizikova S.A., Ushakova G.Y., Ostanin A.A., Pospelova T.I., Chernykh E.R.
|
| Vol 15, No 1 (2013) |
CUP-syndrome: the present view of the problem (a review of literature) |
|
|
Levitskaya N.V., Lewitzki V., Komarov I.G., Nemtsova M.V., Poddubnaya I.V.
|
| Vol 16, No 3 (2014) |
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma |
|
|
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
|
| Vol 15, No 1 (2013) |
Current approach to adjuvant therapy for breast cancer (a review) |
|
|
Conte P., Guarneri V.
|
| Vol 24, No 2 (2022) |
Current concepts of neuroendocrine cancer of the prostate: a clinical case and review of the literature |
(Rus)
|
|
Chizh G.A., Tyutrina Y.A., Protsenko S.A., Dzhelialov E.S., Latipova D.H.
|
| Vol 17, No 4 (2015) |
Current possibilities in diagnosis and treatment of diffuse large B cell lymphoma in children and adolescents: results of Pediatric Hematology and Oncology Research Institute of N.N.Blokhin Russian Cancer Research Center, international experience |
|
|
Levashov A.S., Kovrigina A.M., Valiev T.T., Belyaeva E.S., Popa A.V., Mentkevich G.L.
|
| Vol 26, No 3 (2024) |
Current state of care for cancer patients with HIV in Russia: Data from an oncologist survey |
(Rus)
|
|
Levkovskiy O.V., Ivanov S.A., Falaleeva N.A., Galitsyna A.B., Syadrin M.G.
|
| Vol 26, No 3 (2024) |
Current technologies of response assessment in rectal cancer after neoadjuvant treatment: A review |
(Rus)
|
|
Orlov A.E., Kaganov O.I., Frolov S.A., Blinov N.V., Okulevich N.B.
|
| Vol 24, No 2 (2022) |
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes |
(Rus)
|
|
Snegovoy A.V., Kononenko I.B.
|
| Vol 18, No 5 (2016) |
Current treatment of chronic lymphocytic leukemia. New opportunities and new difficulties |
|
|
Samoylova O.S.
|
| Vol 17, No 3 (2015) |
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer |
|
|
Knyazev R.I., Poddubnaya I.V., Barinov V.V., Bokin I.I.
|
| Vol 13, No 1 (2011) |
Dannye dolgosrochnogo nablyudeniya podtverzhdayut, chto razrabotannyy kompaniey Novartispreparat TasignaR prevoskhodit preparat GlivekR po snizheniyu riska progressirovaniyazabolevaniya u patsientov s vpervye diagnostirovannym khronicheskim mieloleykozom |
|
|
- -.
|
| Vol 11, No 4 (2009) |
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade |
|
|
Lichinitser M.R., Semenov N.N.
|
| Vol 17, No 2 (2015) |
Dental prevention of complications of chemotherapy hematologic diseases in children |
|
|
Lutskaya I.K., Andreyeva V.A., Zinovenko O.G.
|
| Vol 25, No 4 (2023) |
Dermatological toxicity in the treatment of malignant tumors in children: A review |
(Rus)
|
|
Belysheva T.S., Shatokhina E.A., Komarova A.D.
|
| Vol 20, No 1 (2018) |
Dermatomyositis and polymyositis in breast cancer patients: a case reports |
(Rus)
|
|
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
|
| Vol 23, No 1 (2021) |
Detection and monitoring of minimal residual disease in acute megakaryoblastic leukemia in children |
(Rus)
|
|
Palladina A.D., Popa A.V., Valiev T.T., Nikitaev V.G., Chernysheva O.A., Kupryshina N.A., Serebryakova I.N., Shvedova T.V., Kondratchik K.L., Tupitsyn N.N.
|
| Vol 22, No 3 (2020) |
Detection of disseminated tumor cells and their relationship with a population of bone marrow lymphocytes in patients with non-small cell lung cancer |
(Rus)
|
|
Djumanazarov T.M., Chulkova S.V., Tupitsyn N.N., Chernysheva O.A., Allakhverdiev A.K., Palladina A.D., Kupryshina N.A., Kolbatskaya O.P., Kononetz P.V., Akhmedov B.B., Gerasimov S.S.
|
| Vol 26, No 1 (2024) |
Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results |
(Rus)
|
|
Orlova K.V., Demidov L.V.
|
| Vol 25, No 1 (2023) |
Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series |
(Rus)
|
|
Shevchuk A.S., Krylov A.S., Knyazev R.I., Afanasieva K.V.
|
| Vol 24, No 4 (2022) |
Development of a prognostic model in patients with metastatic bone lesions to choose surgical treatment: retrospective study |
(Rus)
|
|
Buharov A.V., Kurilchik A.A., Barashev A.A., Derzhavin V.A., Yadrina A.V., Erin D.A., Elkhov D.O., Aliev M.D., Kaprin A.D.
|
| Vol 18, No 2 (2016) |
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype |
(Rus)
|
|
Karabina E.V., Zhukova L.G.
|
| Vol 17, No 3 (2015) |
Diagnosis and treatment of diffuse large B cell lymphoma in children and adults (review of literature) |
|
|
Levashov A.S., Valiev T.T., Kovrigina A.M., Popa A.V., Mentkevich G.L.
|
| Vol 19, No 3 (2017) |
Diagnosis and treatment of malignant trophoblastic tumors: errors, dangers, complications (review of the literature) |
(Rus)
|
|
Gasanbekova Z.A., Aliev S.A., Meshcheryakova L.A., Kozachenko V.P., Kuznetsov V.V.
|
| Vol 20, No 3 (2018) |
Diagnosis and treatment of metastatic melanoma of unknown primary |
(Rus)
|
|
Krylovetskaya M.A., Komarov I.G., Karseladze D.A.
|
| Vol 26, No 4 (2024) |
Diagnosis of growing teratoma syndrome: A review |
(Rus)
|
|
Nechushkina I.V., Susuleva N.A., Boychenko E.I., Nechushkina V.M., Kerimov P.A., Ryabov A.B.
|
| Vol 20, No 4 (2018) |
Diagnosis of metastatic pulmonary disease: review |
(Rus)
|
|
Komarov I.G., Belova O.S.
|
| Vol 24, No 3 (2022) |
Diagnostic potential of endosonography in primary and secondary esophageal tumors: retrospective study |
(Rus)
|
|
Khalaev Z.V., Suleymanov E.A., Malikhova O.A., Tumanyan A.O., Krylovetskaia M.A., Kontsevaya A.Y., Salimova A.A., Makarova M.V.
|
| Vol 25, No 1 (2023) |
Diagnostic significance of CA-62 cancer antigen for early detection and differential diagnosis of non-small cell lung cancer: results of the blind clinical trials |
(Rus)
|
|
Tcherkassova J.R., Prostyakova A.I., Tsurkan S.A., Suganov N.V., Boroda A.M., Zhilenkova A.V., Pirogova J.N., Sangadzhieva Z.D., Rusanov A.S., Rozhkov A.A., Fatyanova A.S., Nikitina N.M., Bagmet N.N., Sekacheva M.I.
|
| Vol 6, No 1 (2004) |
Diagnosticheskie algoritmy kompleksnogo monitoringa pri spetsial'nom lechenii rasprostranennogo raka yaichnikov |
|
|
Khvastunov R.A., Stolorenko V.V., Lyutaya E.D., Devyatchenko T.F., Egin E.I.
|
| Vol 5, No 1 (2003) |
Diagnostika i khirurgicheskoe lechenie paragangliom shei |
|
|
Duditskaya T.K., Matyakin E.G.
|
| Vol 3, No 3 (2001) |
Diagnostika i lechenie infektsionnykh oslozhneniy pri febril'nykh neytropeniyakh u detey, bol'nykh ostrymi leykozami |
|
|
Ivanova L.F., Dmitrieva N.V., Durnov L.A.
|
| Vol 15, No 1 (2013) |
Diagram of differential diagnostics of stages of ovarian cancer |
|
|
Antoneeva I.I., Abakumova T.V., Gening T.P., Gening S.O.
|
| Vol 22, No 4 (2020) |
Differential diagnosis and treatment of primary peritoneal cancer and mesothelioma |
(Rus)
|
|
Abdullaev A.G., Kozlov N.A., Schakhpazyan N.K., Tsigankova A.V.
|
| Vol 23, No 1 (2021) |
Differential diagnosis and treatment of rare forms of primary peritoneal tumors – solitary fibrous and desmoplastic small round cell tumors |
(Rus)
|
|
Abdullaev A.G., Kozlov N.A., Schakhpazyan N.K., Tsigankova A.V.
|
| Vol 20, No 3 (2018) |
Differential diagnosis of lung cancer and tuberculosis: review |
(Rus)
|
|
Belova O.S., Komarov I.G.
|
| Vol 22, No 4 (2020) |
Differentiated thyroid cancer |
(Rus)
|
|
Bel’tsevich D.G., Mudunov A.M., Vanushko V.E., Rumiantsev P.O., Mel’nichenko G.A., Kuznetsov N.S., Podvyaznikov S.O., Alymov Y.V., Poliakov A.P., Fadeev V.V., Bolotin M.V., Sevriukov F.E., Krylov V.V., Fedenko A.A., Bolotina L.V., Zharov A.A., Falaleeva N.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
|
| Vol 16, No 2 (2014) |
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board |
|
|
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
|
| Vol 18, No 5 (2016) |
Difficulties of diagnosing of the Langerhans histiocytosis |
|
|
Shatokhin Y.V., Snezhko I.V., Kuzub E.I., Shatokhina O.N., Matsionis A.E., Pavilaytite P.E., Nagornaya G.Y., Gerasimova O.V., Burnasheva E.V., Ryabikina E.V.
|
| Vol 26, No 2 (2024) |
Diffuse large B-cell lymphoma and follicular lymphoma: problem state in Russia |
(Rus)
|
|
Poddubnaya I.V., Babicheva L.G.
|
| Vol 25, No 3 (2023) |
Diffuse large B-cell lymphoma: strokes to the epidemiological portrait. A review |
(Rus)
|
|
Poddubnaya I.V., Babicheva L.G., Bariakh E.A.
|
| Vol 24, No 4 (2022) |
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region |
(Rus)
|
|
Zhuikova L.D., Ananina O.A., Sirotina A.S., Pikalova L.V., Fokin V.A., Kononova G.A.
|
| Vol 23, No 4 (2021) |
Disseminated Kaposi sarcoma with osseous metastases in patients with HIV infection. Case report |
(Rus)
|
|
Ognerubov N.A., Antipova T.S.
|
| Vol 11, No 1 (2009) |
Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya |
|
|
Zhukova L.G.
|
| Vol 14, No 1 (2012) |
Dlitel'nyy effekt kombinirovannogolecheniya metastaticheskogo rakazheludka (klinicheskiy sluchay) |
|
|
Khvastunov R.A., Ivanov A.I.
|
| Vol 26, No 2 (2024) |
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review) |
(Rus)
|
|
Editorial B.
|
| Vol 12, No 3 (2010) |
Dobavlenie Zomety (zoledronata)k ad\"yuvantnoy endokrinoterapiiuvelichivaet vyzhivaemost' bol'nykhrannim retseptor-pozitivnym rakommolochnoy zhelezy |
|
|
Zhukov N.V.
|
| Vol 23, No 1 (2021) |
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021 |
(Rus)
|
|
Board E.
|
| Vol 8, No 1 (2006) |
Dopolnitel'nye kliniko-laboratornye faktory prognoza pri diffuznoy krupnokletochnoy V-kletochnoy limfome |
|
|
Babicheva L.G., Poddubnaya I.V.
|
| Vol 5, No 2 (2003) |
Dostizheniya sovremennoy khimioterapii |
|
|
Poddubnaya I.V.
|
| Vol 14, No 1 (2012) |
Dotsetaksel v ad\"yuvantnoy terapiirannego raka molochnoy zhelezy bezporazheniya limfaticheskikh uzlov (N0) |
|
|
Artamonova E.V.
|
| Vol 23, No 3 (2021) |
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives |
(Rus)
|
|
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
|
| Vol 18, No 2 (2016) |
Dural non-Hodgkin’s lymphomas |
(Rus)
|
|
Babicheva L.G., Baikov V.V., Leenman E.E., Vinogradova Y.N., Ilyin N.V., Ryabchikova V.V., Poddubnaya I.V.
|
| Vol 21, No 3 (2019) |
Durvalumab in the treatment of locally advanced non-small cell lung cancer after chemoradiotherapy in a real practice |
|
|
Sakaeva D.D., Ruchkin V.V., Goncharova O.V., Abbasova R.R., Mufazalov F.F.
|
| Vol 19, No 3 (2017) |
Dynamics of circulating tumor cells during neoadjuvant chemotherapy in patients with locally-advanced breast cancer |
(Rus)
|
|
Nenakhova Y.N., Lyadov V.K., Poddubnaya I.V.
|
| Vol 14, No 2 (2012) |
Dzhevtana® (kabazitaksel) - novyy preparat dlya lecheniya metastaticheskogo gormonorezistentnogo raka predstatel'noy zhelezy zaregistrirovan v Rossii |
|
|
- -.
|
| Vol 27, No 1 (2025) |
Ectopic adrenocortical adenoma in the renal sinus: A clinical case |
(Rus)
|
|
Trushkin R.N., Ognerubov N.A., Sokolov S.A., Dolgov S.A., Shcheglov N.E., Sokolov A.A., Urusova L.S., Pachuashvili N.V.
|
| Vol 26, No 1 (2024) |
EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case |
(Rus)
|
|
Magamedova O.R., Oganesyan L.V., Feoktistova P.S., Feidorov I.Y.
|
| Vol 26, No 2 (2024) |
Effect of internal subtype on the efficacy of CDK4/6 inhibitor therapy in advanced HR+/HER2breast cancer: A review |
(Rus)
|
|
Grechukhina K.S., Filonenko D.A., Sukhova M.V., Zhukova L.G.
|
| Vol 21, No 3 (2019) |
Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis |
|
|
Fedyanin M.Y., Polyanskaya E.M., Tryakin A.A., Pokataev I.A., Tjulandin S.A.
|
| Vol 25, No 1 (2023) |
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study |
(Rus)
|
|
Volkova M.I., Feoktistov P.I., Begaliev A.K., Shin A.R., Matveev V.B., Prikhodchenko A.O.
|
| Vol 25, No 1 (2023) |
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis |
(Rus)
|
|
Valiachmetova C.K., Siraev E.R., Izmailov A.A.
|
| Vol 21, No 2 (2019) |
Effective use of the endoscopic vacuum system in the comprehensive treatment of a patient with a defect in the abdominal segment of the esophagus after gastrectomy |
(Rus)
|
|
Abu-Khaidar O.B., Vodoleev A.S., Pirogov S.S., Khomiakov V.M., Riabov A.B.
|
| Vol 25, No 4 (2023) |
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study |
(Rus)
|
|
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova М.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Babicheva A.R., Bondareva I.B., Glonina N.N., Ishchanov D.G., Poddubnaya I.V.
|
| Vol 24, No 1 (2022) |
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases who receive cytotoxic therapy: results of LEGERITY, the second interim analysis of multicenter retrospective-and-prospective observational post-marketing study |
(Rus)
|
|
Nesterova E.S., Saydullaeva A.F., Sherstnev D.G., Shelekhova T.V., Klitochenko T.Y., Khusainova G.N., Lysenko I.B., Lyalina I.S., Demchenkova M.V., Orlova S.A., Proydakov A.V., Betrozova M.V., Fadeeva N.V., Gofman A.A., Marchenko Y.M., Voloshin S.V., Pashneva E.A., Sarzhevskiy V.O., Ishchanov D.G., Poddubnaya I.V.
|
| Vol 26, No 2 (2024) |
Effectiveness and safety of empegfilgrastim (Extimia®) in patients with solid tumors receiving cytotoxic therapy: final results of the DEFENDOR study |
(Rus)
|
|
Snegovoy A.V., Kononenko I.B., Radiukova I.M., Orlova S.A., Sultanbaev A.V., Dubovichenko D.M., Dergunov A.S., Saidullaeva A.F., Repina N.N., Gronskaia I.A., Rossokha E.I., Starostina T.V., Akimova O.V., Vasil'eva I.A., Godzhieva Z.A., Garanina O.I., Gorchkhanova K.I., Machekhina I.S., Gracheva A.S., Danilova A.E., Dmitrakova T.N., Dmitriev V.N., Dmitrochenko M.V., Dylinova O.V., El'kova V.O., Zhelezniak A.V., Zubova I.V., Ivanov A.N., Kaleikina L.P., Komoza I.V., Korolev D.N., Lebedeva L.N., Lebedinets A.A., Mamedguseinova N.N., Miagkova V.S., Matiushina E.I., Narovenkova K.V., Nikolaeva V.M., Novikov D.V., Polonskaia G.E., Rebrina O.V., Safronova M.A., Semenova A.S., Semenova I.A., Skotnikov R.A., Solov'eva E.P., Tat'ianenko A.N., Teterich A.A., Timin V.N., Tolmacheva I.A., Tiugina I.A., Khodkevich A.V., Tsarakhova F.V., Chapko I.S., Shegurova M.M., Shakurova N.R., Shalina A.I., Shumilkina E.A., Iakuba D.V., Ibragimova T.M., Feoktistova P.S., Sorokina I.V., Berezina A.M., Kiseleva P.V., Mironenko O.N., Prosianikova O.N.
|
| Vol 10, No 1 (2008) |
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes) |
|
|
- -.
|
| Vol 3, No 2 (2001) |
Effektivnost' lecheniya tsiklosporinom A bol'nykh mielodisplasticheskimi sindromami v zavisimosti ot formy zabolevaniya |
|
|
Savchenko V.G., Parovichnikova E.N., Kokhno A.V., Mikhaylova E.A., Ol'shanskaya Y.V., Kaplanskaya I.B.
|
| Vol 4, No 3 (2002) |
Effektivnost' lingval'noy formy zofrana pri polikhimioterapii v onkopediatrii |
|
|
Kochurova N.V., Kuleva S.A., Kolygin B.A.
|
| Vol 11, No 1 (2009) |
Effektivnost' Taksoterav neoad\"yuvantnoy i ad\"yuvantnoy khimioterapii raka molochnoy zhelezy (Po materialam mezhdunarodnykh issledovaniy) |
|
|
Makarenko N.P., Poddubnaya I.V.
|
| Vol 12, No 2 (2010) |
Effektivnost' zatrat na ingibitorytirozinkinazy pri khronicheskomPh-pozitivnom mieloleykoze,rezistentnom k imatinibu |
|
|
Rudakova A.V.
|
| Vol 13, No 2 (2011) |
Effektivnost' zatrat nabendamustin v terapii indolentnykhnekhodzhkinskikh limfom |
|
|
Rudakova A.V., Poddubnaya I.V., Zaritskiy A.Y., Stadnik E.A.
|
| Vol 13, No 3 (2011) |
Effektivnost' zatrat nabendamustin v terapii khronicheskogolimfotsitarnogo leykoza |
|
|
Rudakova A.V.
|
| Vol 26, No 1 (2024) |
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study |
(Rus)
|
|
Sultanbaev A.V., Kolyadina I.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Sultanbaeva N.I., Rakhimov R.R., Lipatov D.O., Menshikova I.A., Izmailov A.A., Lipatova E.E.
|
| Vol 21, No 1 (2019) |
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia |
(Rus)
|
|
Gorbunova V.A., Kolyadina I.V., Kovalenko E.I., Manziuk L.V., Artamonova E.V., Zhukova L.G., Bolotina L.V., Semiglazova T.I., Manikhas A.G., Raevskaia N.A., Itkin I.M., Filonenko D.V., Zhilyaeva L.A., Gol'dberg V.E., Popova N.O., Ponomarenko D.M., Shikina V.E., Suslova I.R., Romanchuk O.V., Kozlov D.V., Rzaev A.S., Marfutov V.V., Andreiashkina I.I., Vladimirova L.I., Mitashok I.S., Tikhanovskaia N.M., Karabina E.V., Mukhametshina G.Z., Khasanova A.I., Safina S.Z., Shaidorov M.V., Morozov D.A., Prokof'eva E.P., Kramskaia L.V., Karandeeva T.V., Evstigneeva I.V., Ovchinnikova E.G., Klement'eva T.P., Khrupalo O.V., Tiuvinova E.V., Sherstnev V.M., Chernov I.S., Kolokolov D.D., Gaisina E.A., Levchenko N.V., Chubenko V.A., Povyshev A.I., Iudina I.V., Vorotilina L.V., Andreeva T.V., Tumanian G.S., Koziakov A.E., Gil'mutdinova L.A., Osipov M.A., Shatokhina A.S., Vazhenina A.A., Chichkanova A.S., Vladimirov V.I., Ivanov A.N., Belokhvostova A.S., Cherniakova E.M., Tul'china E.A., Maklashova S.A., Shkodenko O.N., Kostalanova I.V., Tarasova A.V., Kuz'mina E.S.
|
| Vol 17, No 2 (2015) |
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy |
|
|
Krivorotko P.V., Burdaeva O.N., Nechaeva M.N., Frolova M.A., Kopp M.V., Abrosimova A.A., Ivanov R.A.
|
| Vol 27, No 1 (2025) |
Efficacy and safety of immunotherapy for metastatic renal cell carcinoma: A retrospective study |
(Rus)
|
|
Lyadova M.A., Fedorinov D.S., Nersesova T.A., Gridneva Y.V., Volkova M.I., Lyadov K.V., Kuzmina E.S., Antonova T.G., Pokataev I.A., Galkin V.N., Poddubnaya I.V.
|
| Vol 25, No 3 (2023) |
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study |
(Rus)
|
|
Samoylenko I.V., Demidov L.V., Moiseenko F.V., Dvorkin M.V., Demidova S.A., Protsenko S.A., Stroyakovskiy D.L., Kozlov V.V., Odintsova S.V., Kirtbaya D.V., Tantsyrev D.A., Mochalova A.S., Orlova R.V., Mukhametshina G.Z., Fadeeva N.V., Fomin E.A., Chapko Y.S., Tarasova A.V., Ermakov N.B., Shemerovskiy A.K., Vaschenko V.A., Chistyakov V.M., Zinkina-Orikhan A.V., Lin'kova Y.N., Kryukov F.B., Sorokina I.V., Siliutina A.A.
|
| Vol 15, No 1 (2013) |
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies |
|
|
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
|
| Vol 17, No 3 (2015) |
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer |
|
|
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
|
| Vol 24, No 4 (2022) |
Efficacy of immunotherapy (Prolgolimab) and targeted therapy (Trametinib and Dabrafenib, Cobimetinib and Vemurafenib) in adult patients with metastatic or unresectable skin melanoma: matching-adjusted indirect comparison |
(Rus)
|
|
Sapozhnikov K.V., Sokolova V.D., Sableva N.A., Tolkacheva D.G.
|
| Vol 15, No 2 (2013) |
Efficiency of denosumab in giant cell tumor of the bone |
|
|
Semenov N.N.
|
| Vol 15, No 1 (2013) |
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results |
|
|
Garbuzov M.I.
|
| Vol 4, No 4 (2002) |
Ekspressiya molekulyarno-biologicheskikh markerov i ikh prognosticheskaya znachimost' pri sinovial'noy sarkome |
|
|
Keshta R.A., Stepanova E.V.
|
| Vol 10, No 3 (2008) |
Ekstranodal'nye nekhodzhkinskie limfomy s porazheniem myagkikh tkaney |
|
|
Bykov D.A., Subortseva I.N., Ozdoeva T.K., Tupitsyn N.N., Tumyan G.S., Sorokin E.N., Kondrat'eva T.T., Kovrigina A.M., Poddubnaya I.V., Semenova A.A., Khakuy R.A., Osmanov D.S.
|
| Vol 3, No 1 (2001) |
Ekzemestan (aromazin) v sovremennoy endokrinoterapii bol'nykh rakom molochnoy zhelezy |
|
|
Lichinitser M.R.
|
| Vol 23, No 3 (2021) |
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia |
(Rus)
|
|
Bialik T.E., Vorob'ev V.I., Ionin V.A., Ysebaert L., Kaplanov K.D., Mendeleeva L.P., Nikitin E.A., Ptushkin V.V., Samoilova O.S., Stadnik E.A.
|
| Vol 22, No 1 (2020) |
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution |
(Rus)
|
|
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
|
| Vol 25, No 3 (2023) |
Endobronchial metastasis of melanoma: a clinical case |
(Rus)
|
|
Ognerubov N.A., Palkina E.E., Sayapin O.E., Ognerubova M.A.
|
| Vol 25, No 3 (2023) |
Endoscopic criteria for early differential diagnosis of gastritis-like form of primary non-Hodgkin's lymphomas and gastric cancer: A prospective study |
(Rus)
|
|
Lozovaia V.V., Malikhova O.A., Tumanyan A.O., Gusarova O.A.
|
| Vol 23, No 4 (2021) |
Endoscopic esophageal stenting in combination with chemoradiation therapy: A review |
(Rus)
|
|
Ivanov A.I., Popov V.A., Burmistrov M.V.
|
| Vol 23, No 1 (2021) |
Endoscopic semiotics of metastatic bronchial tumors |
(Rus)
|
|
Kontsevaya A.Y., Krylovetskaia M.A., Malikhova O.A., Komarov I.G.
|
| Vol 2, No 3 (2000) |
Endoskopicheskaya diagnostika ekstranodal'noy limfosarkomy u detey |
|
|
Gubin A.N., Poddubnyy B.K., Kuvshinov Y.P., Nechipay A.M., Belousova N.V., Arkhipov V.V., Kiselev A.V., Ordukhanyan Z.S., Peterson I.S.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya diagnostika i lazernaya destruktsiya raka gortani |
|
|
Ungiadze G.V., Poddubnyy B.K., Belousova N.V., Kontsevaya A.Y.
|
| Vol 2, No 3 (2000) |
Endoskopicheskaya khirurgiya opukholevykh i posleoperatsionnykh stenozov u bol'nykh rakom pishchevoda i zheludka |
|
|
Kuvshinov Y.P., Poddubnyy B.K., Efimov O.N., Stilidi I.S., Smirnov O.M., Malikhova O.A., Gannenko I.P.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya retrogradnaya pankreatokholangiografiya v differentsial'noy diagnostike opukholey podzheludochnoy zhelezy |
|
|
Kuvshinov Y.P., Poddubnyy B.K., Kormnov V.G., Pirogov S.S.
|
| Vol 7, No 3 (2005) |
Endoskopicheskaya semiotika i diagnostika limfom glotochnogo kol'tsa Pirogova-Val'deyera |
|
|
Belousova N.V., Poddubnyy B.K., Ungiadze G.V., Arkhipov V.V., Gubin A.N.
|
| Vol 11, No 2 (2009) |
Epidemiologiya gastrointestinal'nykh stromal'nykh opukholey. Registr v Rossii: pervyy opyt |
|
|
Nikulin M.P., Stilidi I.S.
|
| Vol 14, No 4 (2012) |
Epidemiologiya kolorektal'nogo raka v Krasnodarskom krae |
|
|
Potemin S.N., Kazantseva M.V., Elizbaryan K.S., Davidenko I.S., Davidenko O.V.
|
| Vol 23, No 4 (2021) |
Epidemiology and status of specialized medical care for patients with cutaneous T-cell lymphomas: A survey of 163 patients of Russian Federation |
(Rus)
|
|
Kubanov A.A., Karamova A.E., Bogdanova E.V., Znamenskaya L.F., Vorontsova A.A.
|
| Vol 6, No 1 (2004) |
Epirubitsin (Farmorubitsin ) v ad\"yuvantnoy khimioterapii raka molochnoy zhelezy |
|
|
Stenina M.B.
|
| Vol 20, No 1 (2018) |
Epstein-Barr virus in children with classical Hodgkin’s lymphoma |
(Rus)
|
|
Botezatu I.V., Valiev T.T., Dushenkina T.E., Smirnova K.V., Ravshanova R.S., Maksimovich D.M., Likhtenstein A.V., Gurtsevich V.E., Popa A.V., Senyuta N.B.
|
| Vol 9, No 4 (2007) |
Erbituks – ratsional'no sozdannyy preparat dlya lecheniya zlokachestvennykh opukholey |
|
|
Garin A.M., Bazin I.S., Nasyrova R.Y.
|
| Vol 19, No 3 (2017) |
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving |
(Rus)
|
|
Artamonova E.V.
|
| Vol 11, No 4 (2009) |
Eritropoetiny v onkologii:pokazaniya k primeneniyu i problemy |
|
|
Besova N.S.
|
| Vol 23, No 2 (2021) |
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.G.
|
| Vol 23, No 2 (2021) |
Erythropoietin or darbepoetin for patients with cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Lienhard D.A.
|
| Vol 25, No 3 (2023) |
Esophageal anastomosis: experience of open surgery and modern possibilities of video endoscopic technologies. A review |
(Rus)
|
|
Nered S.N.
|
| Vol 7, No 2 (2005) |
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings) |
|
|
Podregul'skiy K.E.
|
| Vol 25, No 4 (2023) |
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
(Rus)
|
|
Yudina E.V.
|
| Vol 26, No 3 (2024) |
Evaluation of the effectiveness of hematopoietic blood stem cell mobilization using empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases: the experience of several centers in the Russian Federation. A retrospective study |
(Rus)
|
|
Nesterova E.S., Mangasarova J.K., Bagova M.O., Fastova E.A., Magomedova A.U., Margolin O.V., Gorenkova L.G., Abdurashidova R.R., Galtseva I.V., Nakastoev I.M., Galuzyak V.S., Baiteryakova O.N., Shcherbakova A.A., Telyashov M.A., Spitsyn V.K., Sukhorukov D.A., Gemdzhian E.G., Zvonkov E.E., Petrova G.D., Sarzhevskiy V.O., Shorokhov N.S., Voloshin S.V., Linnikov S.Y., Drozd M.V., Simashova P.I., Pop V.P., Rukavitsyn O.A., Davydova N.V., Arushanyan M.Y.
|
| Vol 14, No 4 (2012) |
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy |
|
|
Kolyadina I.V., Makarenko N.P., Poddubnaya I.V.
|
| Vol 27, No 1 (2025) |
Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review |
(Rus)
|
|
Grechukhina K.S., Sukhova M.V., Kolyago E.M., Filonenko D.A., Zhukova L.G.
|
| Vol 14, No 1 (2012) |
Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie) |
|
|
Kolyadina I.V., Poddubnaya I.V., Frank G.A., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V., Makarenko N.P., Teterin K.A., Banov S.M., Guzieva Z.M.
|
| 151 - 300 of 1385 Items |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
